Table 1.
hrHPV positivity within the VALGENT‐2 screening population assessed with OncoPredict HPV® SCR assay and GP5+/6+‐PCR‐EIA
Number screened | Number hrHPV+ | % hrHPV+ | |
---|---|---|---|
OncoPredict HPV SCR | 968 | 157 | 16.2% |
GP5+/6+‐PCR‐EIA | 968 | 167 | 17.3% |
Abbreviations: HPV, human papillomavirus; hrHPV, high‐risk HPV.